Australia’s Recce strives for immune-proof super-antibiotic John Ross. There are 2,600+ professionals named "James Graham", who use LinkedIn to exchange information, ideas, and opportunities. WATCH: 90 Seconds With… James Graham, Recce Pharmaceuticals View the profiles of professionals named "James Graham" on LinkedIn. Reblog.
Picture: Adam Yip . James Graham: Recce has been invited to give the opening address at the World Superbug Congress.

Recce is pioneering the global health problem of superbugs. James Graham, Executive Director Recce Ltd ... LinkedIn: Recce Limited 19 For personal use only. April 20, 2020.

Recce Pharmaceuticals Announces Positive Data on RECCE® 327 Against Influenza A Respiratory Virus Infection in Animal Model . “Traditional antibiotics operate by a ‘lock-and-key’ mechanism of action.
James Graham is Dr Graham Melrose’s grandson. Last year Recce changed its name from Recce to the more descriptive Recce Pharmaceuticals. Recce founder and executive chairman Graham Melrose with director James Graham.

So we’re focused on sepsis, septicaemia or blood poisoning, affecting around 30 million people worldwide every year. Adventures, blog bob graham, bob graham recce, bob graham round, bob graham round recce, fell running, fells, lake district 2 Comments on Bob Graham Legs 4&5 Recce With spring showing signs of finally coming through, after a harsh winter, I took the opportunity to run two legs of the Bob Graham Round, in the Lake District with friends looking to take on a round later this year. Our panel discuss what innovation is, why it’s more important than ever and how you can still innovate when cash flow is under pressure. GlobeNewswire. “The need for new antibiotics has never been greater, as bacteria have developed resistance to most currently approved antibiotics,” says James Graham, executive director of Recce Pharmaceuticals. Webinar: COVID-19 — How innovation will boost your ROI . We’ve got a whole new broad spectrum antibiotic, and we’re tackling that problem head on. James Graham: Absolutely.

Share. With a degree in entrepreneurship, Mr Graham invested in Recce in 2013 before joining the company in 2015. The opening address is the R&D address, and it is how Recce's synthetic antibiotics can change the antibiotic business model and lead to better patient outcomes, by way of not only curing superbugs that some patients unfortunately have, but preventing those infections ever taking place. Tweet.